Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Antiplatelet agents reported by researchers at Nippon Steel

March 20, 1998

Modified factor VII interrupts the coagulation cascade

March 18, 1998

Novartis describes new thrombin inhibitors

March 17, 1998

Centocor completes acquisition of reteplase

March 16, 1998

Improved anticoagulants in development at Gyogyszerkutato Intezet

March 16, 1998

Treatment of acute coronary syndromes by thrombin inhibition

March 16, 1998

Boehringer Ingelheim discloses new antiplatelet agents

March 13, 1998

Antithrombotics developed at Warner-Lambert

March 12, 1998

First Rx for HIT type II approved in U.S.

March 10, 1998

U.S. patent covers use of MH-1 to deliver thrombolytics

March 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...